Norethindrone is an active pharmaceutical ingredient used in pharmaceutical manufacturing. It can cause cancer and developmental toxicity according to regulatory labeling requirements.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Restricted or banned substances
Substances on this list are banned or restricted under the named regulation. This page is a compliance reference — verify your obligations under applicable law.
CAS 68-22-4
Retinol
pharmaceutical raw material
Sulfadiazine
pharmaceutical raw material
Cycloserine
pharmaceutical raw material
(RS)-hydroxyzine
pharmaceutical raw material
Levonorgestrel
pharmaceutical raw material
Norgestrel
pharmaceutical raw material
(17R)-norethindrone acetate
pharmaceutical raw material
Norethindrone enanthate
pharmaceutical raw material
The international HS code for Norethindrone (CAS 68-22-4) is 2937.23.
2937.23
2937 23 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
VIKNJXKGJWUCNN-XGXHKTLJSA-N
C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34